GYRE – gyre therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Gyre Therapeutics Announces China's NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment [Yahoo! Finance]
Gyre Therapeutics Announces China’s NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Gyre Therapeutics GAAP EPS of -$0.02 misses by $0.09, revenue of $37.2M beats by $1.76M [Seeking Alpha]
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Form 10-K GYRE THERAPEUTICS, INC. For: Dec 31
Form 8-K GYRE THERAPEUTICS, INC. For: Mar 10
Form 8-K GYRE THERAPEUTICS, INC. For: Mar 12
Form 8-K GYRE THERAPEUTICS, INC. For: Mar 02
Form 4 GYRE THERAPEUTICS, INC. For: Jan 07 Filed by: Zhang Ping
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.